Type 1 Diabetes
Showing of 4 results
University Hospitals Is the First Ohio Site to Offer Breakthough Lantidra Treatment for Type 1 Diabetes
Innovations in Diabetes & Endocrinology | Spring 2026
Creating Novel Care Pathways for Individuals at Risk for Type 1 Diabetes
Innovations in Diabetes & Metabolic Care | Fall 2025
FDA Approval of Islet Cell Transplant Marks Milestone for UH’s Leading Endocrinologist
Innovations in Diabetes & Metabolic Care | Fall 2024 In 2023, the U.S. Food and Drug Administration (FDA) approved Lantidra™ (donislecel), a breakthrough allogeneic (donor) pancreatic islet cellular therapy for individuals with Type 1 diabetes...
University Hospitals Offers Infusion Shown to Delay Progression of Type 1 Diabetes
Innovations in Diabetes & Metabolic Care | Fall 2024
Results are loading...